ell motility on ECM critically depends on the cellular response to force from the matrix. We find that force-dependent reinforcement of ␣ v / ␤ 3 -integrinmediated cell-matrix connections requires the receptorlike tyrosine phosphatase ␣ (RPTP ␣ ). RPTP ␣ colocalizes with ␣ v -integrins at the leading edge during early spreading, and coimmunoprecipitates with ␣ v -integrins during spreading on fibronectin and vitronectin. RPTP ␣ -dependent activation of Src family kinases, in particular activation of Fyn, is C required for the force-dependent formation of focal complexes and strengthening of ␣ v / ␤ 3 -integrin-cytoskeleton connections during the initial phase of ECM contact. These observations indicate that Src family kinases have distinct functions during adhesion site assembly, and that RPTP ␣ is an early component in force-dependent signal transduction pathways leading to the assembly of focal complexes on both fibronectin and vitronectin.
Introduction
As cells encounter new regions of the substrate, they develop bonds with new matrix molecules for migration, matrix remodeling, or traction force generation in the area of these adhesion sites. Physical force is critical in the development of the cell-matrix contacts at all stages . ECM molecules are bound to integrins, which initiate intracellular signaling events causing integrins to connect with the cytoskeleton (Felsenfeld et al., 1996) . As the rearward transport of the cytoskeleton develops force on the connection, the connection is reinforced in concert with the binding of focal contact proteins (Riveline et al., 2001; Galbraith et al., 2002) . This strengthening of integrin-cytoskeleton linkages is blocked by the tyrosine phosphatase inhibitor phenylarsine oxide (Choquet et al., 1997) , suggesting the involvement of tyrosine phosphatases in force transduction pathways.
Integrins form the transmembrane link between the cytoskeleton and ECM molecules (Giancotti and Ruoslahti, 1999) . They are composed of two subunits, ␣ and ␤ , and each ␣␤ combination has its own binding and signaling properties. Interestingly, some integrins can bind to several ECM ligands (Giancotti and Ruoslahti, 1999) . The ␣ v / ␤ 3 -integrin, originally described as the vitronectin (VN)* receptor, binds to a variety of plasma and ECM proteins, including vitronectin, fibronectin (FN), fibrinogen, von Willebrand's factor, and bone sialic protein 1 (Krutzsch et al., 1999) . Most of these ligands encode an RGD sequence that is presumed to represent the binding site for ␣ v / ␤ 3 -integrins. ␣ v / ␤ 3 -integrins are major components of focal contacts on FN and VN and localize to the tip of focal contacts where centripetal extension occurs . ␣ v / ␤ 3 -integrins associate with c-Src (Hruska et al., 1995) and the ␤ 3 -cytoplasmic tail of ␣ v / ␤ 3 -integrins has been shown to mediate activation of c-Src in osteoclasts (Feng et al., 2001) .
The family of transmembrane receptor-like protein tyrosine phosphatases (RPTPs) includes a number of proteins sharing the characteristics of an extracellular domain and intracellular PTP-homology domains. RPTPs have been implicated in the regulation of integrin-mediated events (Petrone and Sap, 2000) . The RPTP CD45 associates with ␤ 2 -integrins and the absence of CD45 enhances the adhesion to FN (Shenoi et al., 1999) . In addition, the RPTP LAR localizes to adhesion sites in regions undergoing disassembly (Serra-Pages et al., 1995) . Another member of this family that regulates adhesion events is RPTP ␣ . Overexpression of RPTP ␣ increases substrate adhesion and prevents cell rounding induced by insulin or EGF (Moller et al., 1995; Harder et al., 1998) . More intriguingly, gene inactivation of RPTP ␣ not only delays spreading on FN but also impairs activation of Src family kinases (SFK; Ponniah et al., 1999; Su et al., 1999) . No soluble or cell-surface-anchored ligands are known to bind the extracellular domain of RPTP ␣ (Petrone and Sap, 2000) . It has been suggested that RPTP ␣ forms a symmetrical-inhibited dimer in which a helix-turn-helix wedge element from one monomer is inserted into the catalytic cleft of the other monomer (Jiang et al., 2000) . Upon activation, RPTP ␣ associates with SFK such as c-Src, Fyn, and c-Yes (Zheng et al., 1992; Harder et al., 1998; Su et al., 1999) . RPTP ␣ dephosphorylates the negative regulatory tyrosine phosphate (Tyr529 in murine c-Src), causing c-Src activation (den Hertog et al., 1993; Zheng et al., 2000) .
Here, we show that RPTP ␣ associates with ␣ v / ␤ 3 -integrins during early spreading. In addition, we show that this association is required for the activation of SFK, the assembly of focal complexes, and the strengthening of integrincytoskeleton bonds on both FN and VN. Moreover, we provide evidence that RPTP ␣ is a critical part of an early force-dependent signal transduction cascade.
Results
␣ v / ␤ 3 -integrin-mediated cell spreading depends on RPTP ␣ To further characterize the role of RPTP ␣ in integrin function, we compared the spreading of fibroblasts derived from RPTP ␣ -expressing (RPTP ␣ ϩ / ϩ ) or RPTP ␣ -deficient (RPTP ␣ Ϫ / Ϫ ) mice on FN and VN. Cell spreading on FN depended on the expression of RPTP ␣ (Fig. 1 A; Su et al., 1999 (Fig. 1, A and D) . Interestingly, there was no difference in the spreading ability on laminin (LA), suggesting a substrate dependency (Fig. 1 B) .
Because FN can interact with ␣ v / ␤ 3 -integrins, spreading on FN substrates may involve the ␣ v / ␤ 3 -integrin. This integrin was expressed on all cells studied, as indicated by protein expression (Fig. 1 C) and FACS ® analysis (unpublished data). To determine the contribution of ␣ v / ␤ 3 -integrins, we plated cells on FN substrates with or without adhesion blocking, monoclonal anti-␣ v or anti-␤ 3 antibodies (both 25 g/ml), or the cyclic peptide GPenGRGDSPCA (GPen; 0.5 mM). At this concentration, GPen is a selective, competitive inhibitor of the ␣ v / ␤ 3 -integrin that inhibits activation of intracellular signaling (Etienne-Manneville and Hall, 2001 ) and does not block ␣ 5 / ␤ 1 -integrins (Pierschbacher and Ruoslahti, 1987) . Indeed, anti-␣ v or anti-␤ 3 antibodies, as well as GPen, drastically reduced cell spreading on VN substrates (Fig. 1 D) . In contrast, FN pretreatment with either GPen or with anti-␣ v or anti-␤ 3 antibodies led to a twofold reduction of spread RPTP␣ ϩ/ϩ and RPTP␣ Ϫ/Ϫwt cells 30 min after plating (Fig. 1 E) . Surprisingly, there was no further reduction in the number of spread RPTP␣ Ϫ/Ϫ or RPTP␣ Ϫ/Ϫvec cells after pretreatment with GPen or with anti-␣ v or anti-␤ 3 antibodies (Fig. 1 E) . Together, these results indicate that the RPTP␣-dependent differences in cell spreading on FN and VN substrates are mediated by the ␣ v / ␤ 3 -integrin. RPTP␣ transiently colocalizes with ␣ v -integrins Next, we wanted to determine whether RPTP␣ colocalizes with ␣ v /␤ 3 -integrins. RPTP␣ Ϫ/Ϫ cells were transiently transfected with an RPTP␣ construct in which the D2 phosphatase domain was replaced by YFP (Buist et al., 2000) . To confirm functionality, we performed spreading assays with RPTP␣-YFP-transfected RPTP␣ Ϫ/Ϫ cells and found a spreading ability similar to the RPTP␣ ϩ/ϩ cells (Fig. 2 B) . Indirect immunofluorescence was used to visualize the ␣ vintegrins and paxillin. Confocal microscopy revealed that RPTP␣ colocalized with ␣ v -integrins and paxillin at the leading edge on both FN and VN 30 min after plating in spreading cells (Fig. 2 A, a-e and k-o). After 240 min, all cells were spread and RPTP␣ was diffusely localized in the membrane (Fig. 2 A, f-j and p-t), whereas colocalization of ␣ v -integrins with paxillin occurred in the area of focal contacts ( Fig. 2 A, j and t). On LA, there was no localization of RPTP␣ to the leading edge in spreading cells (Fig. 2 C) . Thus, we find evidence of a transient association between RPTP␣ and ␣ v /␤ 3 -integrins during the early phases of focal complex formation on both FN and VN.
RPTP␣ transiently associates with ␣ v -integrins and cooperates with ␣ v /␤ 3 -integrins in the activation of downstream signaling on both FN and VN To further investigate the relationship between RPTP␣ and ␣ v /␤ 3 -integrins, we performed coimmunoprecipitation studies. We were able to coimmunoprecipitate RPTP␣ in anti-␣ v -integrin immunoprecipitates of spreading RPTP␣ ϩ/ϩ cells after pretreatment with a water-soluble cross-linker on both FN and VN. This association was restricted to the early phases of spreading because there was no coimmunoprecipitation after 240 min. Furthermore, activation of ␣ v /␤ 3 -integrins was necessary for the formation of the complex because cells kept in suspension for 60 min or cells pretreated with GPen did not show association of RPTP␣ with ␣ v /␤ 3 -integrins. In addition, this interaction was specific for ␣ v -integrins because anti-␣ 5 -integrin immunoprecipitates did not contain RPTP␣ (Fig. 3 A) .
To elucidate the functional relevance of an association of ␣ v /␤ 3 -integrins with RPTP␣, we performed Western blotting with a phosphospecific anti-SFK antibody (autophosphorylation on Tyr416). On both, FN and VN, SFK activity was three times lower in RPTP␣ Ϫ/Ϫ cells than it was in the RPTP␣ ϩ/ϩ cells. Interestingly, the pretreatment of RPTP␣ ϩ/ϩ cells with GPen significantly reduced SFK activation 15 min after plating. However, there was no further reduction in the amount of SFK activity in the RPTP␣ Ϫ/Ϫ cells on either substrate after pretreatment with GPen. Consistent results were obtained using an antibody specific for the dephosphorylated tyrosine 527 in c-Src. In addition, reexpression of wild-type RPTP␣ restored the ability to activate SFKs (Fig. 3 B) . Together, these results suggest functional cooperation of ␣ v /␤ 3 -integrins with RPTP␣ in the activation of SFKs. Because the antibody we used recognizes several SFKs, we cannot determine if SFKs other than c-Src are activated, but the RPTP␣ substrates Fyn and c-Yes are likely possibilities.
RPTP␣ modulates the formation of focal complexes in association with ␣ v /␤ 3 -integrins via activation of Fyn
To study more directly the interplay between RPTP␣ and ␣ v /␤ 3 -integrins, we observed the distribution of GFP-tagged paxillin on different substrates. Paxillin is a focal adhesionassociated adaptor protein that is a known marker for focal adhesions and focal complexes (Beningo et al., 2001) . GFPpaxillin distribution in distinct adhesion sites versus cytoplasmic localization was analyzed in spread cells 30 min after plating. In RPTP␣ ϩ/ϩ cells on both substrates, GFP-paxillin distributed to peripheral stripes in the majority of cells ( 
4, A [a and g] and B). In contrast, in RPTP␣
Ϫ/Ϫ cells, there was more than twofold lower focal complex or contact formation at early times. GFP-paxillin remained mainly cytoplasmic and localized to the leading edge ( (Fig. 4 C) . To differentiate which SFK is responsible for the assembly signal, we cotransfected c-Src, Fyn, c-Yes, and GFP-paxillin into SYF cells. Interestingly, cotransfection with Fyn led to full rescue in the ability to form distinct adhesion sites. In sharp contrast, the transfection of either c-Src or c-Yes did not restore the formation of focal complexes. To transfer these findings, we cotransfected c-Src, Fyn, and c-Yes alone and combinations thereof with GFP-paxillin into RPTP␣ ϩ/ϩ and RPTP␣ Ϫ/Ϫ cells. Interestingly, the coexpression of Fyn led to a dramatic increase in the number of cells exhibiting focal complexes or contacts. In striking contrast, coexpression of c-Src led to reduction in focal contact formation at early times in RPTP␣ ϩ/ϩ cells and only to a small increase in RPTP␣ (Fig. 4 E) . Expression and activation of the transfected SFK was confirmed by Western blotting with antibodies against the individual SFK and a phosphospecific anti-SFK antibody (Fig. 4 E) . Together, these data strongly indicate that the assembly of early focal complexes, as well as contacts, depends on the ␣ v /␤ 3 -integrin and RPTP␣-dependent activation of Fyn.
Loss of RPTP␣ does not affect integrin-ligand interactions
The sensitivity of cell spreading on ECM substrates to RPTP␣ expression raises the possibility that RPTP␣ also modulates integrin-ligand interactions (Hughes and Pfaff, 1998) . To study more directly the role of RPTP␣ in regulating integrin-ligand interactions, we placed ligand-coated beads on the upper surface of spreading fibroblasts with a la- ser trap (Ͻ0.5 m from the leading edge of the cell). This allows the quantification of changes in ligand binding and the dynamics of traction force generation by integrins (Choquet et al., 1997) , which are parameters that are essential to cell spreading and migration (Lauffenburger and Horwitz, 1996) . Beads were coated with a recombinant fragment of FN (FNIII7-10), purified human VN, or BSA. Beads coated with either FNIII7-10 or VN bound to the surface with a similar frequency and significantly better than BSA-coated control beads (Fig. 5 A) . The binding of VN-coated beads was reduced to the level of control beads by pretreatment with GPen (Fig. 5 A) . When FNIII7-10-coated beads were placed and held on the upper surface of cells in the presence of GPen, there was a significant reduction of bead binding on both RPTP␣ ϩ/ϩ and RPTP␣ Ϫ/Ϫ cells (Fig. 5 A) . Together, these results suggest that integrin-ligand interactions are not modulated by RPTP␣ activity. The contrast between the impaired cell spreading and the unaffected bead binding indicates that RPTP␣ may regulate the strength or dynamics of integrin-cytoskeleton interactions.
Loss of RPTP␣ inhibits the strengthening of integrin-cytoskeleton bonds
To evaluate the strength of integrin-cytoskeleton bonds, we placed and held beads on the cell surface using a laser trap. We have shown previously that FN-coated beads bind to cell-surface integrins and are drawn out of the trap in association with the retrograde moving actin cytoskeleton (Choquet et al., 1997) . If the bead is not restrained by the trap after placement on the lamellipodium, it can be dislocated by the laser trap, whereas it is not possible to dislocate a bead that was restrained by the tweezers and pulled out of the trap by the cell. Thus, the cell regulates the strength of integrin-cytoskeleton linkages in response to the rigidity of the laser trap. If there is a defect in this reinforcement process, the bead is only loosely attached to the underlying cytoskeleton, resulting in a greater diffusion rate perpendicular to the direction of rearward movement. This can be quantified using the mean square displacement (MSD) of the bead diffusion (Qian et al., 1991) . Interestingly, after placement of FNIII7-10-and human VN-coated beads onto RPTP␣ Ϫ/Ϫ cells, the MSD of the bead during retrograde transport is two to three times larger than in the RPTP␣ ϩ/ϩ cells (Fig. 5 B) . To confirm the dependency on RPTP␣ expression, we performed the same experiments with RPTP␣ Ϫ/Ϫwt cells. Indeed, reexpression of RPTP␣ drastically reduced the MSD (Fig. 5 B) . Interestingly, the MSD of VN-coated beads is up to six times larger than that for FNcoated beads, suggesting that VN-coated beads are only weakly linked to the cytoskeleton. On the basis of these results, we suggest that RPTP␣ is a selective activator of linkage assembly during the establishment of new adhesion sites.
Reinforcement of integrin-cytoskeleton linkages depends on RPTP␣, ␣ v /␤ 3 -integrins, and activation of Fyn
To further analyze the reinforcement process, we centrifuged onto cells (5 min/50 g) large beads (5.9-m diam) coated with either FNIII7-10 or human VN. In contrast to the small beads used for the laser trap experiments, the large beads can cause the establishment of adhesion sites and, therefore, reinforcement by cellular contractions independent of laser trap restraint (Galbraith et al., 2002) . Interestingly, 74% of the FNIII7-10-coated beads showed accumulation of GFP-paxillin to the bead periphery after 30 min on RPTP␣ ϩ/ϩ cells (46% of VN-coated beads; unpublished data). In contrast, only 14% of the FNIII7-10-coated beads (7% of VN-coated beads; unpublished data) on RPTP␣ Ϫ/Ϫ cells showed redistribution of paxillin to the binding site (Fig. 6, A and B) . Next, we wanted to examine the function of SFK and ␣ v /␤ 3 -integrins in the reinforcement process. Interestingly, pretreatment with GPen reduced the fraction of FNIII7-10-coated beads accumulating paxillin on RPTP␣ ϩ/ϩ cells to 18%, but caused no significant reduction in the number of accumulating beads on the RPTP␣ Ϫ/Ϫ cells (11%; Fig. 6, A and B) . Because the pretreatment with GPen prevented specific binding of VN-coated beads to the upper surface of RPTP␣ ϩ/ϩ and RPTP␣ Ϫ/Ϫ cells (Fig. 5 A) , there was no accumulation of paxillin around VN-coated beads in any case (unpublished data). Coexpression of CSK with paxillin decreased the number of FNIII7-10-coated beads, causing accumulation of paxillin to 16% in RPTP␣ ϩ/ϩ cells, whereas there was no further reduction in RPTP␣ Ϫ/Ϫ cells (8%; Fig. 6, A and B) . Consistent results could be obtained with VN-coated beads (8% for RPTP␣ ϩ/ϩ cells and 5% for RPTP␣ Ϫ/Ϫ cells; unpublished data). We have shown earlier that RPTP␣-dependent activation of Fyn is needed for the formation of focal complexes and contacts, suggesting that it might affect reinforcement. Indeed, coexpression of Fyn with GFP-paxillin led to a significant increase in the number of RPTP␣ Ϫ/Ϫ cells accumulating paxillin around beads (68%). In clear contrast, the coexpression of c-Src or c-Yes did not increase the number of accumulating beads in RPTP␣ Ϫ/Ϫ cells, but coexpression of c-Src reduced the number of cells responding to the beads in RPTP␣ ϩ/ϩ cells to 34% (Fig. 6 C) . Reintroduction of wild-type RPTP␣ into RPTP␣ Ϫ/Ϫ cells restored the ability to assemble paxillin at the binding site (Fig. 6 B) . To confirm ligand specificity, we used Con A-coated beads on RPTP␣ ϩ/ϩ cells, which showed accumulation of GFP-paxillin at the site of adhesion in only 7% of the beads, possibly due to unspecific activation of integrin receptors (Fig. 6 B) . To exclude the possibility of a volume effect around the beads, we transfected RPTP␣ ϩ/ϩ cells with EGFP alone, which did not increase the signal intensity around the beads in any case (Fig. 6 B,  bottom right) . Together, these results are consistent with the idea that RPTP␣-and ␣ v /␤ 3 -integrin-dependent reinforcement of integrin-cytoskeleton linkages is mediated by activation of SFK, in particular, activation of Fyn.
Response to force requires expression of RPTP␣ It has been suggested that phosphatases are involved in the process of mechanotransduction and our data are consistent with the idea that the phosphatase RPTP␣ is required for force-dependent reinforcement of integrin-cytoskeleton linkages. To further address this hypothesis, we designed a laser trap experiment that allowed the visualization of GFPtagged protein dynamics in living cells and tested whether the application of force to small ligand-coated beads (1-m diam) induces the accumulation of focal contact proteins to the adhesion site. As predicted, there was no accumulation of paxillin to the binding site in RPTP␣ ϩ/ϩ cells when the trap was turned off after placement of beads (0%, n ϭ 25; Fig. 7 A, bottom left) . Strikingly, the restraint of FNIII7-10-coated beads with the trap caused accumulation of GFPpaxillin to the binding site within seconds in RPTP␣ ϩ/ϩ cells (82%, n ϭ 22; Fig. 7 A, top) . The paxillin accumulation began as a distinct spot underneath the bead after application of force. However, as the bead was pulled out of the trap by the retrograde motion of the cytoskeleton, force was exerted on the bead, and the pattern of paxillin assembly changed to a ring around the bead (as seen with the large beads). When RPTP␣ Ϫ/Ϫ cells were tested, significantly fewer cells accumulated paxillin to the site of interaction, with (15%, n ϭ 20) or without (0%, n ϭ 24; unpublished data) sustained application of force by the trap (Fig. 7 B) . To confirm a dependency on the expression of RPTP␣, we performed these experiments with RPTP␣ Ϫ/Ϫwt cells. As expected, reexpression of RPTP␣ restored the ability to respond to applied forces with the accumulation of paxillin (65%, n ϭ 23; Fig. 7 C) . These data strongly indicate that RPTP␣ is part of force-dependent signal transduction events, and that it is a crucial component in this process.
Discussion
Our results indicate that RPTP␣ interacts with ␣ v /␤ 3 -integrins, either directly or via adaptor molecules. Although we were able to coimmunoprecipitate a complex of RPTP␣ and ␣ v /␤ 3 -integrins only after cross-linking, the combination of these results with colocalization and cooperation in the activation of SFK suggests the formation of a functional complex. It has been shown for a number of integrins that lateral association with other membrane proteins, such as CD47, is part of the regulatory machinery-controlling integrin function (Brown and Frazier, 2001) . Furthermore, RPTP␣ can interact in cis with other transmembrane receptors such as contactin (Zeng et al., 1999) . In addition, it has been reported that ␣ v /␤ 3 -integrins localize in a rac-dependent process to lamellipodia, where new matrix adhesions are formed (Kiosses et al., 2001) . Furthermore, ␣ v /␤ 3 -integrin-dependent signaling is involved in the reinforcement of integrin-cytoskeleton linkages , and it has been reported that ␣ v / ␤ 3 -integrins influence FN receptor (␣ 5 /␤ 1 -integrin)-dependent migration toward FN (Blystone et al., 1999) .
RPTP␣ is a well-characterized activator of SFK (Ponniah et al., 1999; Su et al., 1999) . Although previous studies have suggested that SFKs are not involved in the assembly of focal contacts (Bockholt and Burridge, 1995; Klinghoffer et al., 1999) , those results were obtained after several hours of incubation on a substratum, where we also find normal focal contact formation in RPTP␣ Ϫ/Ϫ and SYF cells (unpublished data). Our data obtained with coexpression of CSK or with the SYF cells suggest that SFK could transmit a signal for focal complex assembly as well as disassembly. It has been shown recently that SFKs are needed for the maintenance of focal contacts as well as for the tyrosine phosphorylation of proteins in early focal contacts (Volberg et al., 2001 ). c-Src has been shown to regulate focal contact turnover (Fincham and Frame, 1998; Felsenfeld et al., 1999) . On the other hand, Fyn has been reported to be involved in the organization of the cytoskeleton (Stein et al., 1994; Thomas et al., 1995) , and is thought to be responsible for cell volume-dependent changes in the phosphorylation of cytoskeletal and focal contact proteins (Kapus et al., 2000) . In addition, Fyn has been implicated in Rho-mediated cell-cell adhesion events (Calautti et al., 2002) . Our data indicate that SFK, although activated at the same time by the same enzyme, can have opposing effects on the formation of focal contacts. Fyn expression reconstituted almost wild-type levels, whereas expression of c-Src reduced the response to force and the formation of focal complexes. These results are of particular interest because they show that the decrease in force responsiveness with RPTP␣ deficiency can be partially compensated by high levels of Fyn. These data suggest parallel paths of force sensing in structural components (Sawada and Sheetz, 2002) , which might be the target of force-dependent, RPTP␣-mediated activation of Fyn. Therefore, the role of SFK remains controversial, especially during the very beginning of contact formation, and a dual role of SFK in assembly, as well as disassembly/turnover, of focal contacts has to be taken into account.
Recently, it has been shown that overexpression of RPTP␣ leads to an increased cell-substrate adhesion that is associated with increased levels of tyrosine phosphorylation of paxillin, c-Src, and/or focal adhesion kinase (Harder et al., 1998) . In addition, it has been demonstrated that expression of RPTP␣ corresponds with a low tumor grade in breast cancer (Ardini et al., 2000) . Our results indicate that RPTP␣ accelerates the First, upon formation of active lamellipodia, a complex of ␣ v /␤ 3 -integrins and RPTP␣ is formed, localizing to the edge of the lamellipodium. Second, force application to ␣ v /␤ 3 -integrins leads to RPTP␣-dependent activation of SFK. Third, SFK-activation promotes the assembly and the reinforcement of focal complexes at early times. Finally, as focal complexes mature, SFK activity is also required for turnover of adhesion sites.
assembly of adaptor and structural proteins at adhesion sites, thereby stabilizing the link between integrins and the cytoskeleton. It is probably not RPTP␣ itself that is interacting with these proteins; rather, RPTP␣ induces the appropriate signals. Regulated force generation is essential for cell spreading and migration. For spreading to proceed, adhesion sites must be continually remodeled . Our data raise the possibility that the lack of appropriate signals leads to weak linkages and results in an impaired plasticity in the integrin-cytoskeleton linkages needed for rapid cell spreading.
How cells respond to matrix rigidity through force sensing and convert physical cues to biochemical signals is still largely unknown. Besides the mechanical stimuli leading to enlargement of cell adhesions sites (Riveline et al., 2001) , other stimuli affect cell behavior including stretch (MacKenna et al., 1998; Sawada et al., 2001 ) and flow-induced shear stress. Both transmembrane and cytoskeletal mechanisms of force sensing and force transduction have been postulated (Meyer et al., 2000; Sawada and Sheetz, 2002) . In addition, force-dependent unfolding of cryptic protein-protein interaction sites in matrix molecules (Zhong et al., 1998) and recruitment of integrins, leading to activation of MAPKs (MacKenna et al., 1998) , has been suggested. Specifically, ␣ v /␤ 3 -integrins have been implicated in the transmission of mechanical signals (Wilson et al., 1995; Goldschmidt et al., 2001) . Nonetheless, the mechanisms leading to the transformation of force into a biochemical signal are only poorly understood. The data presented here suggest that RPTP␣ localizes with ␣ v /␤ 3 -integrins in a complex and that is a critical component in the force-dependent activation of subsequent signaling steps. Although RPTP␣ has an extracellular domain, which has been shown to interact in cis with other transmembrane proteins (Zeng et al., 1999) , there are no known ligands either soluble or cell-surface bound (Petrone and Sap, 2000) . RPTP␣ may homodimerize on the cell surface (Jiang et al., 2000) and the inactive, dimeric form could be activated by the application of force via ␣ v /␤ 3 -integrins, leading to mechanical separation of the dimer. However, the precise mechanism leading to the activation of RPTP␣ remains speculative.
In mice missing RPTP␣, there are severe hippocampal abnormalities and learning defects consistent with a developmental deficit in radial neuronal migration (unpublished observation). The similarity with Fyn deficiency (Grant et al., 1992) and the documented role of ␣ 3 -and ␣ v -integrins in this process (Anton et al., 1999 ) underlines a possible role for neuronal RPTP␣ in mechanotransduction at points of glial/neuronal contact during migration of neurons.
Materials and methods
Cell culture RPTP␣ fibroblasts were described elsewhere . c-Src-FynYes-deficient cells and c-Src ϩ/ϩ wild-type fibroblasts were obtained from the American Type Culture Collection. All cells were maintained in DME supplemented with 10% (vol/vol) FBS in a humidified atmosphere of 5% CO 2 /95% air at 37ЊC and passaged every 4 d.
Spreading assays
40 g/ml LA, 5 g/ml VN, and the 120-kD chymotryptic fragment of FN (6.6 g/ml) were adsorbed onto tissue culture plastic and blocked with DME/0.5% BSA. Control substrates were blocked without the application of ECM. Cells were briefly trypsinzed and trypsin was inactivated with 1 mg/ml soy trypsin inhibitor in DME. Cells were washed twice (DME/0.5% BSA) and incubated for 30 min with or without GPen (0.5 mM) or anti-␣ v or anti-␤ 3 antibodies (25 g/ml) before plating. Cells were fixed with 2% paraformaldehyde (PFA) and stained with 0.5% toluidine blue in PFA. 20 fields were counted in each well (20ϫ; Olympus). For paxillin distribution assays, cells were transiently transfected using Fugene 6 (3:1) with GFPpaxillin (0.5 g/ml), CSK (0.5 g/ml), wild-type Src, Fyn, or Yes (each 0.5 g/ml) and plated in the presence or absence of GPen. The number of spread cells exhibiting accumulation of GFP-paxillin in distinct adhesion sites (focal complexes or contacts) versus cells having cytoplasmic localization of GFP-paxillin was counted in two independent sets of experiments by independent observers. Pictures were taken using confocal microscopy (100ϫ; Fluoview 300; Olympus).
Immunoprecipitations and Western blotting
For immunoprecipitations, extracellular proteins of 16 ϫ 10 6 cells were cross-linked in the presence of 2 mM dithiobis succinimidyl propionate for 15 min and lysed on ice in 50 mM Tris-HCl, 150 mM NaCl, 50 mM NaF, 1 mM Na 3 VO 4 , 1% NP-40, 1 mM PMSF, 10 g/ml aprotinin, and 10 g/ml leupeptin, pH 7.6 (lysis buffer). The lysates were incubated with polyclonal anti-␣ v or anti-␣ 5 antibodies for 2 h at 4ЊC on a rotating wheel with protein A-Sepharose beads added for the second hour. Beads were washed twice in lysis buffer and twice in wash buffer (50 mM Tris-HCl, pH 8.0) and resuspended in 2ϫ SDS-PAGE sample buffer. For whole cell lysates, cells were lysed and lysates were diluted in 3ϫ SDS-PAGE sample buffer. Equal amounts of proteins were further analyzed by SDS-PAGE followed by Western blotting using polyclonal anti-RPTP␣, anti-␣ v , anti-␤ 3 , phosphospecific anti-SFK, or monoclonal anti-c-Src and dephosphospecific anti-SRC antibodies (clone 28) with immunoreactive bands being visualized by ECL detection.
Immunofluorescence staining
Fibroblasts were transfected with EYFP-RPTP␣ or GFP-paxillin (0.5 g/ml) and plated as described in Spreading assays. Cells were fixed 30 min after plating in 4% PFA for 20 min and permeabilized with 0.2% Triton X-100. Cells were incubated with monoclonal antipaxillin (mouse) and anti-␣ v antibodies (hamster) and a polyclonal phosphospecific anti-SFK antibody for 1 h followed by detection with Alexa-labeled (488, 568, and 647 nm) secondary antibodies. Samples were further analyzed by confocal microscopy (Fluoview 300; Olympus).
Bead assays
0.91-and 5.9-m beads were coated as described previously (Felsenfeld et al., 1996) . In brief, carbodiimide-derivitized latex beads were coupled with ovalbumin (800 g per 0.5-ml beads). Beads were derivitized with biotin and coated with avidin neutralite (150 g per 50-l beads). Finally, beads were coupled with biotinylated FN (FNIII 7-10; 0.61 g per g/l beads) or VN (0.83 g per g/l beads) and blocked with BSA-biotin (67 g per 50-l beads).
For bead binding assays, cells were briefly lifted and plated on LAcoated coverslips. Beads were held for 3 s 0.2-0.5 m from the leading edge, using a 100-mW (40 pN/m) optical gradient laser trap setup (Axiovert 100TV; Carl Zeiss Microlmaging, Inc.) that was calibrated as described elsewhere (Choquet et al., 1997) . For MSD assays, ligand-coated beads were held in the laser trap on the cell surface for 30 s or until the bead had moved Ͼ500 nm from the trap center. The x and y coordinates were determined from video micrographs using single particle tracking routines performed using Isee Software (Invision Corporation/Silicon Graphics O2). Tracking accuracy was 5-10 nm for 1-m beads. The MSD was calculated using an algorithm modified from Qian et al. (1991) .
For reinforcement assays using large beads (5.9 m), cells were transiently transfected with GFP-paxillin, and ligand-coated beads were spun (5 min/50 g) onto the cells. Binding was assessed by confocal microscopy and image analysis using ImageJ (1.24 d; http://rsb.info.nih.gov/ij/). Beads were scored if the signal intensity was more than twice surrounding area within 10 m from the leading edge. For real-time paxillin recruitment assays, cells were transiently transfected and treated as described above. Beads were held on the cell surface until the bead had moved out of the trap. Pictures were taken using a cooled CCD camera (Coolsnapfx) mounted to the trap set up (model IX70; Olympus) and analyzed using ImageJ.
Materials
Monoclonal anti-␣ v and -␤ 3 antibodies were from BD Biosciences. Polyclonal anti-␣ v , anti-␣ 5 , and anti-␤ 3 antibodies were from CHEMICON International, Inc. The monoclonal antipaxillin antibody was from Transduc-
